CapsoVision Inc (CV)

Currency in USD
12.90
-0.19(-1.45%)
Closed·
12.900.00(0.00%)
·
CV is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
12.5013.09
52 wk Range
3.4315.37
Key Statistics
Prev. Close
12.9
Open
13
Day's Range
12.5-13.09
52 wk Range
3.43-15.37
Volume
117.82K
Average Volume (3m)
139.83K
1-Year Change
-
Book Value / Share
0.44
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CV Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
6.00
Downside
-53.49%
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations

CapsoVision Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

CapsoVision Company Profile

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. It offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). The company also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoAccess, a Capsule data access system; CapsoView, a data access reading device for viewing capsule videos; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. It serves gastrointestinal medical practices, clinics, and hospitals. The company sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.

Compare CV to Peers and Sector

Metrics to compare
CV
Peers
Sector
Relationship
P/E Ratio
−26.8x−3.8x−0.6x
PEG Ratio
-−0.130.00
Price/Book
29.6x3.9x2.6x
Price / LTM Sales
46.2x3.1x3.2x
Upside (Analyst Target)
−54.2%45.4%41.8%
Fair Value Upside
Unlock29.2%5.1%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 6.00
(-53.49% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Benchmark
Buy5.00-61.24%5.00Maintain14/11/2025

Earnings

Latest Release
Nov 13, 2025
EPS / Forecast
-0.17 / --
Revenue / Forecast
3.54M / --
EPS Revisions
Last 90 days

People Also Watch

FAQ

What Is the CapsoVision (CV) Share Price Today?

The live CapsoVision share price today is 12.90

What Stock Exchange Does CapsoVision (CV) Trade On?

CapsoVision is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for CapsoVision?

The stock symbol (also called a 'ticker') for CapsoVision is "CV."

What Is the Current CapsoVision Market Cap?

As of today, CapsoVision market capitalisation is 604.28M.

What Is CapsoVision's (CV) Earnings Per Share (TTM)?

The CapsoVision EPS is currently -1.69 (Trailing Twelve Months).

When Is the Next CapsoVision Earnings Date?

CapsoVision's next earnings report will be released on 25 Feb 2026.

Is CV a Buy or Sell From a Technical Analyst Perspective?

Based on today's CapsoVision moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has CapsoVision Stock Split?

CapsoVision has split 0 times. (See the CV stock split history page for full effective split date and price information.)

How Many Employees Does CapsoVision Have?

CapsoVision has 90 employees.

What is the current trading status of CapsoVision (CV)?

As of 24 Dec 2025, CapsoVision (CV) is trading at a price of 12.90, with a previous close of 12.90. The stock has fluctuated within a day range of 12.50 to 13.09, while its 52-week range spans from 3.43 to 15.37.

What Is CapsoVision (CV) Price Target According to Analysts?

The average 12-month price target for CapsoVision is USD6, with a high estimate of USD7 and a low estimate of USD5. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an -53.49% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.